trending Market Intelligence /marketintelligence/en/news-insights/trending/x12excv9azr6osdau_xp4g2 content esgSubNav
In This List

Ampio Pharmaceuticals chief scientific officer to retire

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Ampio Pharmaceuticals chief scientific officer to retire

Ampio Pharmaceuticals Inc. said David Bar-Or will retire as chief scientific officer, effective Sept. 30.

Bar-Or will remain on the Englewood, Colo.-based biopharmaceutical company's board.

He said he plans to do some projects at the Trauma Research Center where he serves as research director for eight medical institutions.